 |
市场调查报告书
商品编码
1977714
全球细胞重编程市场规模、份额、趋势和成长分析报告（2026-2034年）Global Cell Reprogramming Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
细胞重编程市场预计将从 2025 年的 4.6554 亿美元成长到 2034 年的 10.2116 亿美元，2026 年至 2034 年的复合年增长率为 9.12%。
受再生医学和干细胞研究进展的推动，全球细胞重编程市场正经历强劲成长。细胞重编程技术能够将体细胞转化为诱导多功能细胞，用于治疗应用。组织工程和疾病模型领域研发的不断深入也促进了市场扩张。此外，生物技术创新领域投资的持续成长进一步加速了市场发展。
主要成长要素包括对个人化医疗和再生医学日益增长的需求。学术机构和生物技术公司正在投资研发旨在提高效率和安全性的新型再程式化技术。不断扩大的临床研究活动和政府资助也促进了这一成长。此外，基因编辑工具的进步也对细胞再程式化技术有了补充作用。
展望未来，再生医学的商业化和细胞重编程技术的进步有望推动市场发展。新兴经济体对先进研究基础设施的投资将创造新的机会。伦理考量和法规结构预计将影响科技的普及应用。随着再生医学的进步，全球细胞重编程市场预计将迎来显着的长期成长。
目录
第一章：引言
第二章执行摘要
第三章 市场变数、趋势与框架
- 市场谱系展望
- 渗透率和成长前景分析
- 价值链分析
- 法律规范
- 标准与合规性
- 监管影响分析
- 市场动态
- 市场驱动因素
- 市场限制因素
- 市场机会
- 市场挑战
- 波特五力分析
- PESTLE分析
第四章：全球细胞重编程市场：依技术划分
- 市场分析、洞察与预测
- 利用仙台病毒进行重新编程
- mRNA再程式化
- 附加体重再程式化
- 其他的
第五章 全球细胞重编程市场：依应用划分
- 市场分析、洞察与预测
- 调查
- 治疗用途
第六章：全球细胞重编程市场：依最终用途划分
- 市场分析、洞察与预测
- 研究和学术机构
- 生物技术和製药公司
第七章 全球细胞重编程市场：依地区划分
- 区域分析
- 北美市场分析、洞察与预测
- 我们
- 加拿大
- 墨西哥
- 欧洲市场分析、洞察与预测
- 英国
- 法国
- 德国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太市场分析、洞察与预测
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 其他亚太国家
- 拉丁美洲市场分析、洞察与预测
- 巴西
- 阿根廷
- 秘鲁
- 智利
- 其他拉丁美洲国家
- 中东和非洲市场分析、洞察与预测
- 沙乌地阿拉伯
- UAE
- 以色列
- 南非
- 其他中东和非洲国家
第八章 竞争情势
- 最新趋势
- 公司分类
- 供应链和销售管道合作伙伴（根据现有资讯）
- 市场占有率和市场定位分析（基于现有资讯）
- 供应商情况（基于现有资讯）
- 策略规划
第九章：公司简介
- 主要公司的市占率分析
- 公司简介
- Thermo Fisher Scientific Inc
- Allele Biotechnology And Pharmaceuticals Inc
- ALSTEM Inc
- STEMCELL Technologies Inc
- Merck KGaA
- Bio-Techne Corporation
- REPROCELL Inc
- Lonza Group AG
- FUJIFILM Corporation（Fujifilm Cellular Dynamics International Inc.）
- Mogrify Limited
The Cell Reprogramming Market size is expected to reach USD 1021.16 Million in 2034 from USD 465.54 Million (2025) growing at a CAGR of 9.12% during 2026-2034.
The Global Cell Reprogramming Market is witnessing strong growth driven by advancements in regenerative medicine and stem cell research. Cell reprogramming technologies enable conversion of somatic cells into induced pluripotent stem cells for therapeutic applications. Increasing research in tissue engineering and disease modeling is supporting market expansion. Growing investment in biotechnology innovation is further accelerating development.
Key growth drivers include rising demand for personalized therapies and regenerative treatments. Academic institutions and biotech firms are investing in novel reprogramming techniques to enhance efficiency and safety. Expanding clinical research activities and supportive government funding are contributing to growth. Additionally, advancements in gene editing tools are complementing cell reprogramming technologies.
Looking ahead, the market is expected to benefit from commercialization of regenerative therapies and improved reprogramming methods. Emerging economies investing in advanced research infrastructure will create new opportunities. Ethical considerations and regulatory frameworks will influence adoption. As regenerative medicine progresses, the Global Cell Reprogramming Market is poised for substantial long-term growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Technology
- Sendai Virus-based Reprogramming
- mRNA Reprogramming
- Episomal Reprogramming
- Others
By Application
- Research
- Therapeutic
By End Use
- Research & Academic Institutes
- Biotechnology & Pharmaceutical Companies
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, Allele Biotechnology and Pharmaceuticals Inc, ALSTEM Inc, STEMCELL Technologies Inc, Merck KGaA, BioTechne Corporation, REPROCELL Inc, Lonza Group AG, FUJIFILM Corporation Fujifilm Cellular Dynamics International Inc, Mogrify Limited
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL CELL REPROGRAMMING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Technology
- 4.2. Sendai Virus-based Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. mRNA Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Episomal Reprogramming Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL CELL REPROGRAMMING MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Therapeutic Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL CELL REPROGRAMMING MARKET: BY END USE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End Use
- 6.2. Research & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Biotechnology & Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL CELL REPROGRAMMING MARKET: BY REGION 2022-2034(USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Technology
- 7.2.2 By Application
- 7.2.3 By End Use
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Technology
- 7.3.2 By Application
- 7.3.3 By End Use
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Technology
- 7.4.2 By Application
- 7.4.3 By End Use
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Technology
- 7.5.2 By Application
- 7.5.3 By End Use
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 South East Asia
- 7.5.9 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Technology
- 7.6.2 By Application
- 7.6.3 By End Use
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL CELL REPROGRAMMING INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Thermo Fisher Scientific Inc
- 9.2.2 Allele Biotechnology And Pharmaceuticals Inc
- 9.2.3 ALSTEM Inc
- 9.2.4 STEMCELL Technologies Inc
- 9.2.5 Merck KGaA
- 9.2.6 Bio-Techne Corporation
- 9.2.7 REPROCELL Inc
- 9.2.8 Lonza Group AG
- 9.2.9 FUJIFILM Corporation (Fujifilm Cellular Dynamics International Inc.)
- 9.2.10 Mogrify Limited
